NCT05338164

Brief Summary

This randomized controlled trial is aimed to evaluate pregnancy and neonatal outcomes in twin pregnancies, in which a cervical cerclage is placed due to the shortening of the cervix with or without visible fetal membranes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2021

Completed
9 days until next milestone

Study Start

First participant enrolled

December 20, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 21, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

February 27, 2025

Status Verified

February 1, 2025

Enrollment Period

2.7 years

First QC Date

December 11, 2021

Last Update Submit

February 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of preterm birth at ≤33+6, and ≤31+6 weeks with cervical length ≤25 mm

    Rate of preterm births stratified by gestational age inside the included women

    Immediate reporting of cases at time of delivery through study completion, an average of 1 year

Secondary Outcomes (4)

  • Subgroup analysis for the risk of preterm birth at ≤33+6, and ≤31+6 weeks with cervical length ≤15 mm

    Immediate reporting of cases at time of delivery through study completion, an average of 1 year

  • The incidence of miscarriage.

    Immediate reporting of cases at time of miscarriage through study completion, an average of 1 year

  • Incidence of cervico-vaginal infection

    after confirmation of infection through study completion, an average of 1 year

  • Neonatal outcomes in both groups

    early neonatal through study completion, an average of 1 year

Study Arms (2)

Cerclage group

EXPERIMENTAL

cervical cerclage between 14 and 20 weeks will be done by one of the three authors.

Procedure: cervical cerclage

No Cerclage group

NO INTERVENTION

Routine follow up without cerclage

Interventions

McDonald cervical cerclage will be applied using Mersaline braided tape with double needle. Single stitch (4 bites) will be applied as close as possible to the level of internal os. The Knot will be put either anterior or posterior according to the surgeon desire.

Cerclage group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant ladies
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18-45 years.
  • Dichorionic twins.
  • Transvaginal sonographic cervical length is \<25 mm with or without internal os dilatation ≥10 mm at 14-20 weeks gestational age.
  • Asymptomatic.

You may not qualify if:

  • Triplets and quadruplets.
  • Monochorionic twins.
  • Threatened/ inevitable miscarriage
  • Bulging membranes through the external os.
  • Extremes of age.
  • Major fetal anomalies.
  • Known cases with uterine anomalies e.g. bicornuate uterus, uterus didelphis… etc.
  • Fetal demise.
  • Fetal reduction in the current pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine, Zagazig University

Zagazig, Sharqia Province, 44519, Egypt

Location

MeSH Terms

Conditions

Premature Birth

Interventions

Cerclage, Cervical

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Obstetric Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Mohamed Lashiin, M.D.

    Zagazig University

    PRINCIPAL INVESTIGATOR
  • Amro El Nemr, M.D.

    Zagazig University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

December 11, 2021

First Posted

April 21, 2022

Study Start

December 20, 2021

Primary Completion

August 27, 2024

Study Completion

October 31, 2024

Last Updated

February 27, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations